FMX101 4% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Acne Vulgaris: Efficacy and Safety From a Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study

Main Article Content

Joseph Raoof
Deirdre Hooper
Angela Moore
Martin Zaiac
Tory Sullivan
Leon Kircik
Edward Lain
Jasmina Jankivevic
Iain Stuart


acne, minocycline


Abstract not available.


Disclosures: Study sponsored by Foamix Pharmaceuticals.

Copyright 2018 SKIN

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>